Evusheld Prophylaxis Improves Social Interactions, Anxiety, Depression, Agoraphobia, and Quality of Life in Blood Cancer Patients

Evusheld Prophylaxis Improves Social Interactions, Anxiety, Depression, Agoraphobia, and Quality of Life in Blood Cancer Patients

Evusheld is a combination injection of tixagevimab and cilgavimab and is indicated for the pre-exposure prophylaxis of COVID-19 in adults and adolescents aged 12 years and older. Its use has been advocated for immunosuppressed individuals, such as blood cancer patients, although uptake varies signif...

Full description

Bibliographic Details
Main Authors: Annabel M. Follows, Charlotte Clark, Catherine Dye, Lorraine King, Gail Skillings, Grace Byrne, Vicki Tinkler, George A. Follows
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:COVID
Subjects:
COVID-19
Evusheld
EQ5D-3L
blood cancer
Online Access:https://www.mdpi.com/2673-8112/3/5/48

Similar Items

Similar Items